Hair shedding during GLP-1 treatment is a real concern, and a modest change on the scale does not make the question go away. In one recent Zepbound discussion, a reader described visible thinning after about 10 pounds of weight loss over 12 weeks. Others reported similar worries, while some pointed to nutrition or another hair condition. These reports matter, but they cannot identify the cause for any one person.
What the Zepbound trials found
The FDA prescribing information for Zepbound reports hair loss in 4% to 5% of people assigned tirzepatide in two pooled weight-reduction trials, versus 1% assigned placebo. It says these reports were associated with weight reduction. Women reported hair loss more often than men in both the tirzepatide and placebo groups.
Those numbers show that hair loss was reported more often in the treatment groups. They do not establish whether a particular person’s shedding comes from the medicine itself, weight change, eating changes, or another cause. Nor do they establish that everyone who sheds lost weight rapidly.
What newer records add
A 2026 study of electronic health records compared people prescribed semaglutide or tirzepatide with matched people who had not used those medicines. The researchers found higher recorded odds of nonscarring hair loss, including telogen effluvium, among the medicine users. Hair-loss diagnoses also tended to occur alongside a lower later body mass index. Because this was an observational records study, it cannot fully separate a medicine effect from weight change, nutrition, or other causes. It also cannot predict whether one person’s hair will grow back.
“Hair loss” covers more than one pattern. Diffuse shedding and patterned thinning raise different questions, and timing alone cannot distinguish them. A clinician or dermatologist can assess the pattern, history, and relevant health factors when shedding is severe, persistent, or worrying.
Do biotin or copper peptides help?
Some people in the Zepbound discussion say biotin or hair products helped. Those experiences deserve a hearing, but a product used alongside other changes cannot be credited from a comment alone. The NIH Office of Dietary Supplements says there is little scientific evidence for biotin products promoted for hair, skin, and nail health, although biotin deficiency can cause hair loss. It also notes that high amounts of biotin may distort some lab results, including thyroid tests. Tell your care team about any supplements before testing.
PeptideWHY has a separate guide to GHK-Cu hair research. The small human study discussed there measured eyebrow outcomes with a topical serum. It did not test GHK-Cu for GLP-1-associated shedding and does not establish it as a treatment for this problem.
What to take from this
Hair loss is a reported adverse reaction during tirzepatide treatment, and people describe it even when their weight loss feels modest. The evidence does not give a single explanation for everyone. The useful next question is what kind of hair loss is occurring and what else changed around the same time. That takes an individual assessment, not a conclusion from a forum thread.
Sources: FDA Zepbound label; 2026 observational study; NIH biotin fact sheet; community discussion.